Apple is seeking a patent for an iPhone that has a display that wraps around the edges of the device, expanding the viewable area and eliminating all physical buttons. The patent application reveals that Apple has put some thought into a device that takes advantage of a new generation of displays, which don't have to be flat and rigid like today's liquid-crystal displays, or LCDs.
It's not exactly like selling picks and shovels during the California gold rush. But the patent wars now raging across corporate America have simultaneously generated a lot of interest in New York-based startup Article One Partners (AOP), whose global network of researchers uncover the "prior art" that enables its clients to shoot down low quality patent lawsuits.
Having blood drawn and analyzed to diagnose disease is a process that can take a few days, but what if your doctor could perform this analysis in moments, right before your eyes? That's the promise of "lab-on-a-chip" technology, and researchers are working on a variety of fronts to remove technical roadblocks. A new idea addresses the issue of sensor shelf life, showing how some such chips might be made to last for months or more until needed.
Eastman Kodak will receive about $525 million from the sale of its digital imaging patents, money the struggling photo pioneer says will help it emerge from bankruptcy protection in the first half of next year. The company filed for bankruptcy protection in January after struggling to adapt to the shift to digital photography.
Each year NIST releases a report on technology transfer from federal laboratories, detailing efforts to transfer the results of public investment in research to meet marketplace and other needs. The newest technology transfer report tallies the thousands of patents, cooperative agreements, licenses, and other pathways by which these transfers happened in 2010.
A recent review of retractions in medical and biological peer-reviewed journals finds the percentage of studies withdrawn because of fraud or suspected fraud has jumped substantially since the mid-1970s. In 1976, there were fewer than 10 fraud retractions for every 1 million studies published, compared with 96 retractions per million in 2007.
From Napster to iTunes to Pandora, the methods by which the public can obtain and share music have rapidly progressed. Future groundbreaking innovations may need to wait, though, as the next generation of technology is being stymied by the very copyright laws that seek to protect the industry, says Rutgers-Camden University professor Michael Carrier in a new article for a law journal..
University of Texas at Austin physicists have been awarded a U.S. patent for an invention that could someday be used to turn nuclear waste into fuel, thus removing the most dangerous forms of waste from the fuel cycle. The researchers have patented the concept for a novel fusion-fission hybrid nuclear reactor that would use nuclear fusion and fission together to incinerate nuclear waste.
Agilent Technologies Inc. announced that it was awarded a significant patent for comparative genomic hybridization (CGH) methods. CGH methods help researchers study genetics and cancer in both basic and clinical research.
With billions of dollars and control of the U.S. smartphone and computer tablets markets at stake, jury selection began Monday in a closely watched trial between two of the world's leading tech companies over patents. Cupertino-based Apple is demanding $2.5 billion in damages from Samsung Electronics Co., an award that would dwarf the largest patent-related verdict to date.
According to recent data released by Google, the search engine giant has logged more than 2.5 million requests in the last 11 months to remove links believed to be violating Microsoft’s copyrights. This exceeded the number of complaints about material produced by entertainment companies pushing for tougher online piracy laws.
Industrial biotechnology companies rely heavily on patents to attract investment to fund R&D. The recent America Invents Act stands to have a significant impact on technology innovators such as biotech firms, and two recently published papers from patent law experts help explain the extent of these shifts.
EOS announced that it has filed a patent infringement lawsuit against Phenix Systems. The lawsuit alleges infringement of U.S. Patent Nos. 5,753,274 and 6,042,774 through the manufacture, sale, and use of the PXL, PXM, PXS, and PXS Dental product lines from Phenix in the U.S.
Google and Oracle faced off in court in San Francisco on Monday, with Oracle intending to rely heavily on Google’s own internal emails to build its case. The dispute hinges on Oracle's allegations that Google's widely used Android software for mobile devices infringes on copyrights and patents that Oracle acquired when it bought Sun Microsystems Inc. for $7.3 billion in 2010.
In a reflection of how patents have become a hot commodity in the high-tech industry in the last few years, AOL Inc. has agreed to sell 800 of its patents and license others to Microsoft Corp. for about $1.06 billion in cash. The news sent AOL shares to their highest level in a year.
Last Friday, the National Science Foundation held a congressional briefing to call attention to its research successes, particularly the process of bringing relevant fundamental research from the laboratory to the marketplace. Particular attention was called to Small Business Innovation Research grant beneficiaries, some of whom shared their success stories at the briefing.
The Supreme Court this week threw out a lower court ruling allowing human genes to be patented. The court overturned patents belonging to Myriad Genetics Inc. of Salt Lake City on two genes linked to increased risk of breast and ovarian cancer.
According to a recent study by a University at Buffalo economist, firms that make a previously patented innovation accessible to competitors increase overall likelihood of improving upon that breakthrough while also raising profits for the original innovator and market welfare. Further, the practice of free-licensing may correspond to an evolutionary step in the study of patents and their effects on innovation.
Financially troubled Proview Electronics Co., a computer monitor and LED light maker, says it registered the iPad trademark in China and elsewhere more than a decade ago and wants Apple to stop selling or making the popular tablet computers under that name. Whatever the outcome, the dispute highlights the rising stakes of the trademark name game in the increasingly lucrative China consumer market, one that most global companies cannot afford to miss out on regardless of the risks.
The National Science Foundation and the U.S. Census Bureau has revamped and expanded their Business R&D and Innovation Survey, which collects information from a nationally representative sample of about 40,000 companies. The results indicate that trademarks and trade secrets are the most important form of intellectual property protection, ahead of copyrights and patents.
Should patent and commercialization activities by faculty count toward tenure and promotion? A large percentage of universities still do not include commercialization considerations for tenure and promotion, even six years after Texas A&M University created a stir by adding commercialization considerations as a sixth factor in tenure evaluations.
The pharmaceutical industry won approval to market a record number of new drugs for rare diseases last year, as a combination of scientific innovation and business opportunity spurred new treatments for diseases long-ignored by drug companies. Many of these so-called orphan drugs offer extra patent protections and faster government approval.
Kodak is at a crossroads: It could go the way of Circuit City, or it could prosper after bankruptcy like General Motors. Even in bankruptcy, the company boasts some enviable strengths, including a rich collection of photo patents, and more than $4 billion in annual sales. But it may be too late for a transition.
American Auto-Matrix announced that it resolved its patent infringement lawsuit against TSI Inc. with an amicable and mutually beneficial settlement. The lawsuit, which had been pending in federal court since May 17, 2010, involved AMM’s U.S. Patent number 5,764,579, entitled “System for Controlling Laboratories with Fume Hoods”.
An R&D 100 Award-winning technology from National Renewable Energy Laboratory has recently been licensed to Natcore, a Colorado-based company that is able to commercialize the “black silicon” technology with its liquid phase deposition process.